Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Cutting the duration of treatment also cut the likelihood of a cure.
The Grand Plan Study showed that a multidisciplinary program can produce a high cure rate with little loss to follow-up.
The three-drug combination cured most people who had experienced previous treatment failure.
The short treatment could make transplantation of organs from donors with HCV more safe, effective and economical.
Mavyret was associated with the most improvement in post-traumatic stress disorder symptoms.
A four-drug combination cured all individuals who had experienced prior treatment failure.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
People who received a shortened course of antiviral therapy were less likely to be cured.
Louisiana saw a bump-up in HCV prescriptions after the alternate model was introduced.
The Epclusa and Mavyret combination pills are now indicated for kids as young as age 3.
With many hepatitis C treatments on the market today, patients may ask which hepatitis C treatment is right for me? What’s the difference?
Drugmaker AbbVie teams with Michigan’s Department of Corrections and Department of Health and Human Services to launch “We Treat Hep C.”
Regardless of cirrhosis status, Mavyret led to high sustained virologic response rates in Latinos and other groups with hep C.
These recommendations are based on the World Health Organization’s guidelines.
A recent study of the direct-acting antiviral regimen included people who contracted hep C within the previous 12 months.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.